Security key
34960Q307
Fortress Biotech, Inc. - Common Stock, par value $0.001 per share (FBIO)
CUSIP: 34960Q307
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 4,960,694
- Total 13F value
- $9,226,455
- Share change
- +48,353
- Put/Call ratio
- 132%
- SEC-reported price per share
- $1.86
- Number of holders
- 49
- Value change
- +$452,125
- Number of buys
- 26
- Number of sells
- 20
- Shares outstanding
- 33,557,755
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
49
Top holders
10
FBIO full security history
Ownership snapshot
Full 13F holder table
Fortress Biotech, Inc. SEC filings
Fortress Biotech, Inc. company facts
Fortress Biotech, Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of FBIO - Fortress Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cambridge Investment Rese...
Disclosed value leader
Cambridge Investment Rese...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
Lead comparable stake: 3%
Showing 1-6 of 15 holder rows.
Quick read
Cambridge Investment Research Advisors, Inc. leads the comparable SEC ownership view at 3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cambridge Investment Research Advisors, Inc.'s linked filing trail.
Comparable ownership
Top 5
Cambridge Investment Research Adv...
3%
VANGUARD GROUP INC
2.2%
PVG ASSET MANAGEMENT CORP
1.4%
Nantahala Capital Management, LLC
0.97%
Kestra Advisory Services, LLC
0.87%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
3%
|
$1,567,000
1,004,365 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
2.2%
|
$1,173,979
752,551 shares
|
— | 31 Mar 2025 |
| PVG ASSET MANAGEMENT CORP |
13F
Company
|
1.4%
|
$736,665
472,221 shares
|
— | 31 Mar 2025 |
| Nantahala Capital Management, LLC |
13F
Company
|
0.97%
|
$507,811
325,520 shares
|
— | 31 Mar 2025 |
| Kestra Advisory Services, LLC |
13F
Company
|
0.87%
|
$456,270
292,481 shares
|
— | 31 Mar 2025 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
0.8%
|
$417,936
267,908 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
49
Shares
4,960,694
Rows available
49
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
46
Q2 2025 holders
49
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|